Recruiting

Breast Reconstruction

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT07335354

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RECONJOINT

Study Details

Brief summary:

The purpose of this study is to find out whether it is practical (feasible) to do a larger study looking at the effectiveness of the Breast Reconstruction Decision Aid Tool (RECONJOINT) for breast reconstruction surgery.

Conditions

Breast Cancer

Study ID

NCT07335354

Start date

Jan 5, 2026

Status verified date

Jul, 2026

Completion date

Jan 5, 2029

Anticipated

Primary completion date

Jan 5, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Participant Inclusion Criteria

Focus Group Participants

  • A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
  • ≥18 years old
  • Considering post-mastectomy breast reconstruction

RCT Participants (Patients)

  • A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record
  • ≥18 years old
  • Considering post-mastectomy breast reconstruction
  • Have an appointment scheduled for consultation with a plastic surgery provider

RCT Participants (Physicians)

  • Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery.

Participant Exclusion Criteria

Focus Group Participants

  • Not considering post-mastectomy breast reconstruction
  • Non-English proficiency

RCT Participants (Patients)

  • Not considering postmastectomy breast reconstruction
  • Recurrent or metastatic breast cancer
  • Male sex
  • Non-English proficiency

RCT Participants (Physicians)

  • Does not provide breast reconstruction care at least 50% of the time
  • Non-English proficiency

Study Design

Enrollment

131 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Other

Interventions and Outcome Measures

Arms

no intervention: Focus Group Participants

Participants will receive usual care

experimental: RECONJOINT/RCT Participants (Patients)

Participants in the RECONJOINT intervention arm will receive the decision aid in addition to enhanced usual care

experimental: RCT Participants (Physicians)

Participating surgeons will be randomized to Enhanced Usual Care or Intervention with a 1:1 ratio

Interventions

RECONJOINT

RECONJOINT is a Breast Reconstruction Decision Aid

Primary outcome measure

  • Feasibility determined by participant accrual [ Time Frame: <60 days after initial reconstructive surgery consult and before pt's breast reconstruction surgery ]

Central Contacts and Locations

Central contacts

Evan Matros, MD

646-608-8044matrose@mskcc.org

Carrie Stern, MD

646-608-8048sternc2@mskcc.org

Locations

Memorial Sloan Kettering Basking Ridge

Recruiting

Basking Ridge, New Jersey, United States, 07920

Contacts

Evan Matros, MD

646-608-8044

Memorial Sloan Kettering Monmouth

Recruiting

Middletown, New Jersey, United States, 07748

Contacts

Evan Matros, MD

646-608-8044

Memorial Sloan Kettering Bergen

Recruiting

Montvale, New Jersey, United States, 07645

Contacts

Evan Matros, MD

646-608-8044

Memorial Sloan Kettering Commack

Recruiting

Commack, New York, United States, 11725

Contacts

Evan Matros, MD

646-608-8044

Memorial Sloan Kettering Westchester

Recruiting

Harrison, New York, United States, 10604

Contacts

Evan Matros, MD

646-608-8044

Memorial Sloan Kettering Cancer Center

Recruiting

New York, New York, United States, 10065

Contacts

Evan Matros, MD

646-608-8044

Memorial Sloan Kettering Nassau

Recruiting

Rockville Centre, New York, United States, 11553

Contacts

Evan Matros, MD

646-608-8044

Duke Cancer Institute (Data collection only)

Recruiting

Durham, North Carolina, United States, 27710

Contacts

Brett Phillips

888-275-3853

More Information

Sponsor

Memorial Sloan Kettering Cancer Center

Last update posted

Jul 9, 2026

Last verified

Jul, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2026-07-09.